News

Completion of new facility in San Diego

January 02, 2024

Proteome Sciences is pleased to announce the completion of installation and setup of equipment in its new US laboratory in San Diego, California. and is therefore now fully operational. 

Trading update for the year 2023

November 30, 2023

The Company announces a trading update to its shareholders.

Launch of Commercial Single Cell Proteomics Services

October 02, 2023

Proteome Sciences plc is pleased to announce the launch of SysQuant® SCP, the commercial service for single cell proteomics using the power of its TMTpro™ isobaric labelling reagents. 

Investor Presentation

September 20, 2023

Investor Presentation

August 30, 2023

Proteome Sciences plc is pleased to announce that Chief Executive Officer, Dr Mariola Soehngen, will provide a live presentation relating to the Half Year Results via the Investor Meet Company platform on 19th September 2023 at 10:00am BST.

Interim results for the six months ended 30 June 2023

August 25, 2023

Proteome Sciences announces its unaudited interim results for the six months ended 30 June 2023.

 

Repayment of Loan to Vulpes Investment Management Private Limited

June 01, 2023

The Directors of Proteome are pleased to announce that the Company has today repaid in full the outstanding loan and associated interest (together totalling £824,424) to Vulpes Investment Management Private Limited originally announced on 2 July 2018 and amended on 30 March 2022.

Result of Annual General Meeting (AGM)

May 17, 2023

The directors of Proteome Sciences are pleased to announce that at the Company's AGM, held at 12.00 p.m. today, all resolutions were duly passed.

 

Annual General Meeting (AGM) Statement

May 17, 2023

Annual General Meeting (AGM) Statement

Proteome Sciences expands into the US: New Facility to open in San Diego

May 12, 2023

Proteome Sciences plc is pleased to announce the expansion of its proteomics services into the United States of America (“US”).